Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 8:15 pm Purchase | 2023-05-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management LP | 2,280,778 5.100% | 2,280,778 (New Position) | Filing History |
| 2023-02-13 10:15 am Purchase | 2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | ALKEON CAPITAL MANAGEMENT LLC | 2,399,252 6.100% | 2,399,252 (New Position) | Filing History |
| 2023-02-10 1:56 pm Sale | 2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 3,418,068 7.600% | -50,876 (-1.47%) | Filing History |
| 2023-02-09 12:01 pm Sale | 2023-02-09 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 4,016,608 10.148% | -1,890,671 (-32.01%) | Filing History |
| 2023-02-06 09:50 am Sale | 2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Victory Capital Management, Inc. | 3,459 0.010% | -2,297,773 (-99.85%) | Filing History |
| 2023-01-20 4:09 pm Purchase | 2023-01-13 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Millennium Management LLC | 2,433,850 5.400% | 2,433,850 (New Position) | Filing History |
| 2022-12-29 4:41 pm Purchase | 2022-12-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC | PFIZER INC PFE | 5,376,344 12.000% | 5,376,344 (New Position) | Filing History |
| 2022-12-27 4:36 pm Sale | 2022-12-22 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 1,787,569 4.500% | -425,002 (-19.21%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 799,341 2.000% | -1,616,006 (-66.91%) | Filing History |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 3,468,944 8.800% | 376,726 (+12.18%) | Filing History |
| 2022-02-11 4:54 pm Sale | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,671,522 9.300% | -1,096,659 (-23.00%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,907,279 14.999% | 454,932 (+8.34%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 2,415,347 6.100% | 536,439 (+28.55%) | Filing History |
| 2022-02-02 3:53 pm Purchase | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Victory Capital Management, Inc. | 2,301,232 5.840% | 2,301,232 (New Position) | Filing History |
| 2021-08-12 4:17 pm Sale | 2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.600% | -254,721 (-10.32%) | Filing History |
| 2021-03-19 6:06 pm Sale | 2021-03-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,467,292 6.800% | -298,425 (-10.79%) | Filing History |
| 2021-02-16 12:07 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 3,092,218 8.700% | 450,000 (+17.03%) | Filing History |
| 2021-02-12 6:24 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 4,768,181 13.100% | 4,768,181 (New Position) | Filing History |
| 2021-02-08 10:29 am Purchase | 2021-02-05 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,452,347 14.999% | 2,215,014 (+68.42%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 1,878,908 5.300% | 1,878,908 (New Position) | Filing History |